Cargando…
The research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: A bibliometric analysis from 2013 to 2022
Hematopoietic stem cell transplantation (HSCT) is curative in patients with primary immunodeficiency syndrome. The safety and efficacy of HSCT as a therapeutic option for primary immunodeficiency diseases (PID) have been studied by many research groups. The purpose of our study was to perform a bibl...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063298/ https://www.ncbi.nlm.nih.gov/pubmed/37000105 http://dx.doi.org/10.1097/MD.0000000000033295 |
_version_ | 1785017682521751552 |
---|---|
author | Hu, Siqi Xu, Shixia Lu, Wei Si, Yingjian Wang, Ya Du, Zhenlan Wang, Yi Feng, Zhichun Tang, Xiangfeng |
author_facet | Hu, Siqi Xu, Shixia Lu, Wei Si, Yingjian Wang, Ya Du, Zhenlan Wang, Yi Feng, Zhichun Tang, Xiangfeng |
author_sort | Hu, Siqi |
collection | PubMed |
description | Hematopoietic stem cell transplantation (HSCT) is curative in patients with primary immunodeficiency syndrome. The safety and efficacy of HSCT as a therapeutic option for primary immunodeficiency diseases (PID) have been studied by many research groups. The purpose of our study was to perform a bibliometric analysis of research on HSCT for the treatment of PID, to assess research trends in this field, and note future research priorities. The Web of Science Core Collection (WOSCC) was used to identify relevant publications. VOSviewer and CiteSpace software were used to analyze bibliometric parameters, such as yearly records, authors, grouped authors, countries, institutions, categories and keywords. There are 602 relevant records for the last decade (2013–2022). The top 5 productive authors and high-quality paper journals are listed. Reference co-citations analysis demonstrated recent research trends were “inborn errors of immunity,” “gene editing,” and “enteropathy.” Research on HSCT for the treatment of PID has increased rapidly in the last decade, and bibliometrics are valuable for researchers to obtain an overview of hot categories, academic collaborations and trends in this study field. |
format | Online Article Text |
id | pubmed-10063298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-100632982023-03-31 The research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: A bibliometric analysis from 2013 to 2022 Hu, Siqi Xu, Shixia Lu, Wei Si, Yingjian Wang, Ya Du, Zhenlan Wang, Yi Feng, Zhichun Tang, Xiangfeng Medicine (Baltimore) 4800 Hematopoietic stem cell transplantation (HSCT) is curative in patients with primary immunodeficiency syndrome. The safety and efficacy of HSCT as a therapeutic option for primary immunodeficiency diseases (PID) have been studied by many research groups. The purpose of our study was to perform a bibliometric analysis of research on HSCT for the treatment of PID, to assess research trends in this field, and note future research priorities. The Web of Science Core Collection (WOSCC) was used to identify relevant publications. VOSviewer and CiteSpace software were used to analyze bibliometric parameters, such as yearly records, authors, grouped authors, countries, institutions, categories and keywords. There are 602 relevant records for the last decade (2013–2022). The top 5 productive authors and high-quality paper journals are listed. Reference co-citations analysis demonstrated recent research trends were “inborn errors of immunity,” “gene editing,” and “enteropathy.” Research on HSCT for the treatment of PID has increased rapidly in the last decade, and bibliometrics are valuable for researchers to obtain an overview of hot categories, academic collaborations and trends in this study field. Lippincott Williams & Wilkins 2023-03-31 /pmc/articles/PMC10063298/ /pubmed/37000105 http://dx.doi.org/10.1097/MD.0000000000033295 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | 4800 Hu, Siqi Xu, Shixia Lu, Wei Si, Yingjian Wang, Ya Du, Zhenlan Wang, Yi Feng, Zhichun Tang, Xiangfeng The research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: A bibliometric analysis from 2013 to 2022 |
title | The research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: A bibliometric analysis from 2013 to 2022 |
title_full | The research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: A bibliometric analysis from 2013 to 2022 |
title_fullStr | The research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: A bibliometric analysis from 2013 to 2022 |
title_full_unstemmed | The research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: A bibliometric analysis from 2013 to 2022 |
title_short | The research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: A bibliometric analysis from 2013 to 2022 |
title_sort | research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: a bibliometric analysis from 2013 to 2022 |
topic | 4800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063298/ https://www.ncbi.nlm.nih.gov/pubmed/37000105 http://dx.doi.org/10.1097/MD.0000000000033295 |
work_keys_str_mv | AT husiqi theresearchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT xushixia theresearchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT luwei theresearchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT siyingjian theresearchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT wangya theresearchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT duzhenlan theresearchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT wangyi theresearchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT fengzhichun theresearchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT tangxiangfeng theresearchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT husiqi researchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT xushixia researchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT luwei researchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT siyingjian researchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT wangya researchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT duzhenlan researchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT wangyi researchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT fengzhichun researchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 AT tangxiangfeng researchonthetreatmentofprimaryimmunodeficiencydiseasesbyhematopoieticstemcelltransplantationabibliometricanalysisfrom2013to2022 |